AxelaRx B.V.
Netherlands
1 December 2019 - 30 November 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for AxelaRx B.V. published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 1 | 0.02 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 1 | 0.02 | |
Top articles by Altmetric score in current window
Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery
Nature Communications
2020-06-26
1 December 2019 - 30 November 2020
International vs. domestic collaboration by Share
- 69.01% Domestic
- 30.99% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (2 total)
- AxelaRx B.V., Netherlands
- Domestic institution
Top 10 international collaborators by Share (4 total)
- AxelaRx B.V., Netherlands
- Foreign institution
-
OncoNano Medicine, Inc., United States of America (USA)
(0.14)
-
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA)
(0.11)
-
Aravasc Inc., United States of America (USA)
(0.05)
-
Jph Clinical Development, Inc., United States of America (USA)
(0.05)
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
